Luly Jay R. has been a registered insider since 2003.
As Chief Executive Officer at Enanta Pharmaceuticals, Luly Jay R. last made a transaction on 3/13/2023.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 7 |
71% |
13% |
2% |
75 |
1 Year |
7 |
0% |
-- |
-- |
-- |
| 7 |
57% |
11% |
13% |
46 |
9 Month |
7 |
0% |
-- |
-- |
-- |
| 7 |
43% |
7% |
-2% |
62 |
6 Month |
7 |
0% |
-- |
-- |
-- |
| 8 |
38% |
-2% |
-2% |
47 |
3 Month |
8 |
0% |
-- |
-- |
-- |
| 8 |
63% |
9% |
7% |
37 |
1 Month |
8 |
0% |
-- |
-- |
-- |
| 8 |
75% |
4% |
3% |
22 |
1 Week |
8 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 11 |
91% |
-11% |
-15% |
111 |
1 Year |
11 |
0% |
-- |
-- |
-- |
| 11 |
55% |
2% |
-1% |
75 |
9 Month |
11 |
0% |
-- |
-- |
-- |
| 12 |
42% |
-2% |
3% |
93 |
6 Month |
12 |
0% |
-- |
-- |
-- |
| 13 |
54% |
-4% |
-6% |
73 |
3 Month |
13 |
0% |
-- |
-- |
-- |
| 13 |
46% |
-1% |
4% |
55 |
1 Month |
13 |
0% |
-- |
-- |
-- |
| 13 |
62% |
-1% |
-0% |
21 |
1 Week |
13 |
0% |
-- |
-- |
-- |
| Scorecards Updated 6/14/2023 02:53 PM EST |
Latest Transaction Date: |
3/13/2023 |
| Average days between Transaction and Entered Dates: |
2 |
